7 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Profiles #SideEffects ... #Table #DecisionAid ... #Orals #DM2 #Diabetes ... Endocrinology #Pharmacology
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... drugs. ... #pharmacology #dm2 ... #diabetes #medications ... #overview #management
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
of Antianginal Drugs ... #Antianginal #Medications ... #Cardiology #Pharmacology ... Management #Therapy #Table ... #Overview
Statins intensity, drug interactions, timing of administration and missed doses.

An overview of high, moderate and low
Statins intensity, drug ... An overview of high ... #pharmacology #overview ... #medications #comparison ... #drugs #table
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
tablets, initial dosing ... INR targets #pharmacology ... #overview #review ... #medications #drugs ... #cardiology #warfarin
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #management #algorithm ... #pharmacology # ... treatment #medications ... #decisionaid #cardiology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... to remain stable ... #semaglutide #Diabetes ... #Pharmacology #